Stocklytics score rationale: value 50, quality 56, growth 49.
Financials
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
29710000000
29953000000
30557000000
28913000000
30117000000
31686000000
31227000000
32364000000
33537000000
36364000000
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing…
Forecast
Consensus Buy from 30 analysts. Average price target $97.73, +1.1% versus the current price. Low $83.00. High $115.00.
Analysts have an average 12-month price target of $97.73 for Medtronic (MDT), 1.1% above the current price of $96.69. Of 30 analysts covering the stock, 20 rate it Buy or Strong Buy, 10 Hold, and 0 Sell or Strong Sell, giving a consensus of Buy.
Forecasts are third-party estimates and often wrong. They are not investment advice.
MDT price target
12-month price target
Low
$83.00
Average
$97.73
High
$115.00
The average is 1.1% above the current price of $96.69.
Is Medtronic a buy or sell?
Of 30 analysts, 20 rate Medtronic Buy or Strong Buy, 10 Hold, and 0 Sell or Strong Sell. The consensus label is Buy. That split is not a recommendation.
The Stocklytics Score for MDT is 52 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.
MDT forecast FAQs
What is the MDT price target?
$97.73 average, with a published range of $83.00 to $115.00.
Is Medtronic a buy or sell?
The consensus is Buy from 30 analysts. This is not a recommendation.
What is the Medtronic stock forecast for 2026?
Analysts' average EPS estimate for 2026 on file is $5.52. The average revenue estimate is $36.15 billion.
What will MDT be worth in 2030?
No reliable forecast exists that far out.
When is Medtronic's next earnings report?
The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.
Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.